Advertisement

R&D Progress, stock price volatility, and post-announcement drift: An empirical investigation into biotech firms

  • Bixia Xu
Article

Abstract

I investigate the effects of R&D progress on the dynamics of stock price volatility and the post announcement drift to provide insights into whether or not and how capital markets react to corporate R&D progress in the context of the biotech industry. I find both stock price volatility and the post announcement drift decrease in R&D progress. More importantly, the decrease is proportional to the increase in the drug development success rate driven by R&D progress. Findings suggest that R&D progress conveys useful risk-relevant information, and plays an important role in explaining stock price volatility change and market anomalies.

Keywords

R&D progress Stock price volatility Post-announcement drift 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ball R, Brown P (1968) An empirical evaluation of accounting income numbers. Journal of Accounting Research 6:159–178Google Scholar
  2. Bartov E (1992) Patterns in unexpected earnings as an explanation for post-announcement drift. The Accounting Review 67:610–622Google Scholar
  3. Bartov E, Radhakrishnan S, Krinsky I (2000) Investor sophistication and patterns in stock returns after earnings announcements. The Accounting Review 75:43–63Google Scholar
  4. Bernard V, Thomas J (1989) Post-earnings announcement drift: Delayed price response or risk premium?. Journal of Accounting Research 27:1–36Google Scholar
  5. Bloomfield R, Libby R, Nelson M (2000) Under-reactions and over-reactions: The influence of information reliability and portfolio formation rules. Journal of Financial Markets 3:113–137CrossRefGoogle Scholar
  6. Brockman P, Chung D (2000) An empirical investigation of trading on asymmetric information and heterogeneous prior beliefs. Journal of Empirical Finance 7:417–454CrossRefGoogle Scholar
  7. Bhushan R (1994) An information efficiency perspective on the post-earnings-announcement drift. Journal of Accounting and Economics 18:45–65CrossRefGoogle Scholar
  8. Chambers D, Jennings R, Thomson II R (2002) Excess returns to R&D-intensive firms. Review of Accounting Studies 7:133–158CrossRefGoogle Scholar
  9. Chan L, Lakonishok J, Sougiannis T (2001) The stock market valuation of research and development expenditures. The Journal of Finance LVI:2431–2456Google Scholar
  10. Chae J (2005) Trading volume, information asymmetry, and timing information. The Journal of Finance LX:413–442Google Scholar
  11. DiMasi JA (1995) Success rate for new drug entering clinical testing in the United States. Clinical Pharmacology & Therapeutics 58:1–14CrossRefGoogle Scholar
  12. Dasgupta P, Stiglitz J (1980) Uncertainty, industrial structure, and the speed of R&D. Bell Journal of Economics 11:1–28Google Scholar
  13. Ely K, Simko PJ, Thomas LG (2003) The usefulness of biotechnology firms’ drug development status in the development of research and development costs. Journal of Accounting, Auditing and Finance 18:163–196Google Scholar
  14. Fama E, French K (1993) Common risk factors in the returns on stocks and bonds. Journal of Financial Economics 33:3–56CrossRefGoogle Scholar
  15. Francis J, LaFond R, Olsson P, Schipper K (2003) Accounting anomalies and information uncertainty, Working paper, Duke University, University of Wisconsin, Duke University, and Financial Accounting Standards Board in the U.S.Google Scholar
  16. Foster G, Olsen C, Shevlin T (1984) Earnings releases, anomalies, and the behaviour of securities returns. The Accounting Review 59:574–603Google Scholar
  17. Kellogg D, Charnes JM (2000) Real-option valuation for a biotechnology company. Financial Analysts Journal May/June 76–84Google Scholar
  18. Kim D, Kim M (2003) A multifactor explanation of post earnings announcement drift. Journal of Financial and Quantitative Analysis 38:383–398Google Scholar
  19. Lev B, Sougiannis T (1999) Penetrating the book-to-market black box: the R&D effect. Journal of Business Finance and Accounting 26:419–449CrossRefGoogle Scholar
  20. Liang L (2003) Post-earnings announcement drift and market participants’ information processing biases. Review of Accounting Studies 8:321–345CrossRefGoogle Scholar
  21. Mikhail B, Walter R, Willis H (2000) The effects of experience on security analyst underreaction and post-earnings announcement drift, Working paper, Duck UniversityGoogle Scholar
  22. Riahi-Belkaoui A (2002) Level of multinationality as an explanation for post announcement drift. The International Journal of Accounting 37:413–419Google Scholar
  23. Robbins-Roth C (2000) From Alchemy to IPO: The Business of biotechnology. Perseus PublishingGoogle Scholar
  24. Soffer L, Lys T (1999) Post-earnings-announcements drift and the discussions of predictable information. Contemporary Accounting Research Summer 305–274Google Scholar
  25. Shi C (2003) On the trade-off between the future benefits and riskiness of R&D: a bondholders’ perspective. Journal of Accounting and Economics 35:227–254CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2006

Authors and Affiliations

  1. 1.Wilfrid Laurier UniversityWaterlooCanada

Personalised recommendations